MRI T2 characteristics in somatotroph adenomas following somatostatin analog treatment in acromegaly

Endocrine. 2016 Jul;53(1):327-30. doi: 10.1007/s12020-015-0816-2. Epub 2015 Nov 28.

Ansgar Heck^{1

2}, Kyrre E Emblem³, Olivera Casar-Borota^{4

5}, Geir Ringstad⁶, Jens Bollerslev^{7

8}

¹ Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Rikshospitalet, Nydalen, P.b 4950, 0424, Oslo, Norway. ansgar.heck@medisin.uio.no.
² Faculty of Medicine, University of Oslo, Oslo, Norway. ansgar.heck@medisin.uio.no.
³ The Intervention Centre, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
⁴ Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
⁵ Department of Pathology, Oslo University Hospital, Oslo, Norway.
⁶ Department of Radiology and Nuclear Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
⁷ Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Rikshospitalet, Nydalen, P.b 4950, 0424, Oslo, Norway.
⁸ Faculty of Medicine, University of Oslo, Oslo, Norway.

No abstract available

Publication types